Assessment of fatigue in Moroccan patients with ankylosing spondylitis
Authors:
- Yousra Ibn YacoubYYYousra Ibn Yacoub
- Bouchra AmineBABouchra Amine
- Assia LaatirisALAssia Laatiris
- Redouane AbouqalRARedouane Abouqal
- Najia Hajjaj-HassouniNHNajia Hajjaj-Hassouni
- 28 August 2010
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 29 (11) , 1295-1299
Abstract
This study aims to assess fatigue aspects in Moroccan patients with ankylosing spondylitis (AS), and its relationships with disease-specific variables of activity and severity. A cross-sectional study included patients with ankylosing spondylitis according to New York Classification criteria for the diagnosis of AS. To assess fatigue, the first item of Bath Ankylosing Spondylitis Disease Activity index (BASDAI) and the Multidimensional assessment of fatigue were used (MAF). The evaluation included the activity of the disease (BASDAI), global well-being (Bath Ankylosing Spondylitis Global Index), functional status (Bath Ankylosing Spondylitis Functional Index), enthesitis and health-related quality of life (SF-36 generic instrument). One hundred patients were included (67 men and 33 women), of average age 38.0 years ± 12.9 [18–72]. Our patients had a moderately active and a severe disease. In our data, 60% experienced severe fatigue (BASDAI fatigue ≥ 50 mm) and mean total score of \( {\hbox{MAF}} = {32}.0\pm 20 \). Gender, NSAID therapy and the presence of biological inflammatory syndrome did not influence the MAF scores. Higher scores of fatigue were correlated with functional disability, general well-being, disease activity, enthesitis, and the deterioration of five domains of SF-36. Multivariate regression showed strong relationship between fatigue severity and general well-being and enthesitis. Severe fatigue (MAF) was most related with the domain of physical function. This study state the importance of fatigue in AS patients. The severity of fatigue is associated with disease activity, functional disability, general well-being, and enthesitis. Fatigue influences negatively different aspects of quality of life. Fatigue is an important outcome measure that must be part of routine clinical evaluation of our AS patients.
Keywords
This publication has 16 references indexed in Scilit:
- Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitisClinical Rheumatology, 2010
- Fatigue in patients with ankylosing spondylitis: relationships with disease-specific variables, depression, and sleep disturbanceClinical Rheumatology, 2009
- Assessment of fatigue in patients with ankylosing spondylitisRheumatology International, 2007
- Fatigue in ankylosing spondylitisAnnales de Réadaptation et de Médecine Physique, 2006
- Fatigue et spondylarthrite ankylosanteAnnales de Réadaptation et de Médecine Physique, 2006
- Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self‐reported measuresArthritis Care & Research, 2005
- Measures of fatigue: The Fatigue Questionnaire, Fatigue Severity Scale, Multidimensional Assessment of Fatigue Scale, and Short Form-36 Vitality (Energy/Fatigue) Subscale of the Short Form Health SurveyArthritis & Rheumatism, 2003
- Assessment of fatigue in the management of patients with ankylosing spondylitisRheumatology, 2003
- THE BATH ANKYLOSING SPONDYLITIS PATIENT GLOBAL SCORE (BAS-G)Rheumatology, 1996
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984